Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4651802018 | Alpha/beta-arteether only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4651803011 | Product containing only alpha/beta-arteether in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Alpha/beta-arteether only product in parenteral dose form | est un(e) (attribut) | Product containing only alpha/beta-arteether (medicinal product) | true | Inferred relationship | Some | ||
| Alpha/beta-arteether only product in parenteral dose form | est un(e) (attribut) | médicament contenant alpha/bêta arteether, forme parentérale | true | Inferred relationship | Some | ||
| Alpha/beta-arteether only product in parenteral dose form | Plays role | Antimalarial therapeutic role | true | Inferred relationship | Some | ||
| Alpha/beta-arteether only product in parenteral dose form | a pour principe actif (attribut) | Alpha/beta-arteether (substance) | true | Inferred relationship | Some | 1 | |
| Alpha/beta-arteether only product in parenteral dose form | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Alpha/beta-arteether 75 mg/mL solution for injection | est un(e) (attribut) | True | Alpha/beta-arteether only product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR